…
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
The Ensign Group operates U.S. post-acute healthcare services, including skilled nursing, inpatient rehabilitation, assisted living, home health, hospice and outpatient therapy. Its long-term growth drivers include demographic aging and rising demand for post-acute and home-based care, a roll-up acquisition strategy and expansion into higher-margin therapy services that may benefit from scale and operational efficiencies. Investors may find the company attractive for its diversified care continuum and recurring cash-flow profile.
Key risks include sensitivity to Medicare/Medicaid reimbursement and regulatory changes, operational and integration risks from ongoing acquisitions, staffing shortages and occupancy volatility that investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 289.09M | 258.00M | 217.61M | 116.17M | 115.37M |
| Minority interest | -0.03M | -3.07M | 0.89M | -1.15M | -0.16M |
| Net income | 224.68M | 194.65M | 170.48M | 110.53M | 92.36M |
| Selling general administrative | 158.81M | 151.76M | 129.74M | 110.87M | 100.31M |
| Gross profit | 517.99M | 468.21M | 407.47M | 291.11M | 274.48M |
| Reconciled depreciation | 62.35M | 55.98M | 54.57M | 51.05M | 47.34M |
| Ebit | 296.82M | 260.46M | 223.16M | 129.18M | 128.89M |
| Ebitda | 360.38M | 320.84M | 281.54M | 182.88M | 176.23M |
| Depreciation and amortization | 63.55M | 60.37M | 58.38M | 53.70M | 47.34M |
| Non operating income net other | 1.20M | 4.39M | -5.55M | -13.01M | -13.12M |
| Operating income | 296.82M | 260.46M | 223.16M | 129.18M | 128.49M |
| Other operating expenses | 2728.64M | 2367.00M | 2179.44M | 1907.34M | 1946.64M |
| Interest expense | 8.93M | 6.85M | 9.36M | 15.66M | 15.18M |
| Tax provision | 64.44M | 60.28M | 46.24M | 23.95M | 22.84M |
| Interest income | - | 4.39M | 3.81M | 2.65M | 2.06M |
| Net interest income | -8.93M | -2.46M | -5.55M | -13.01M | -13.12M |
| Extraordinary items | - | - | - | 18.84M | 32.87M |
| Non recurring | - | - | - | - | -1.66M |
| Income tax expense | 64.44M | 60.28M | 46.24M | 23.95M | 22.84M |
| Total revenue | 3025.47M | 2627.46M | 2402.60M | 2036.52M | 2073.47M |
| Total operating expenses | 221.16M | 207.75M | 184.31M | 161.93M | 147.65M |
| Cost of revenue | 2507.48M | 2159.25M | 1995.13M | 1745.42M | 1798.99M |
| Total other income expense net | -7.74M | -2.46M | -5.55M | -13.01M | 1.66M |
| Discontinued operations | - | - | - | 19.47M | 32.87M |
| Net income from continuing ops | 224.65M | 197.72M | 171.36M | 92.21M | 92.53M |
| Net income applicable to common shares | 224.68M | 194.65M | 170.48M | 110.53M | 92.36M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 4177.54M | 3452.02M | 2850.62M | 2545.58M | 2361.91M |
| Intangible assets | 6.53M | 6.44M | 6.38M | 6.62M | 6.45M |
| Other current assets | 35.04M | 36.34M | 48777.00M | 41.33M | 42.92M |
| Total liab | 2680.22M | 2203.22M | 1828.91M | 1727.35M | 1705.77M |
| Total stockholder equity | 1491.87M | 1248.80M | 1021.71M | 818.23M | 656.14M |
| Deferred long term liab | - | 33.27M | 1.95M | 39.69M | 5.28M |
| Other current liab | 544.63M | 425.61M | 399.67M | 450.09M | 239.85M |
| Common stock | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M |
| Capital stock | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M |
| Retained earnings | 1142.65M | 946.34M | 733.99M | 551.05M | 391.52M |
| Other liab | - | 116.77M | 96.44M | 102.09M | 63.39M |
| Good will | 76.87M | 76.87M | 60.47M | 54.47M | 54.47M |
| Other assets | - | 76.93M | 80.19M | 1127.01M | 44.88M |
| Cash | 509.63M | 316.27M | 262.20M | 236.56M | 59.17M |
| Total current liabilities | 734.75M | 582.07M | 523.07M | 562.40M | 343.17M |
| Current deferred revenue | 10.83M | 9.70M | 9.34M | 10.26M | 10.69M |
| Net debt | 1361.67M | 1257.79M | 1003.14M | 877.45M | 1287.69M |
| Short term debt | 86.48M | 69.68M | 55.94M | 51.15M | 47.67M |
| Short long term debt | 3.95M | 3.88M | 3.76M | 2.96M | 2.70M |
| Short long term debt total | 1871.30M | 1574.06M | 1265.34M | 1114.01M | 1346.87M |
| Other stockholder equity | 349.15M | 302.40M | 287.66M | 267.11M | 264.56M |
| Property plant equipment | - | 992.01M | 2027.31M | 778.24M | 767.57M |
| Total current assets | 1046.93M | 781.12M | 639.71M | 582.96M | 411.08M |
| Long term investments | - | - | - | - | 30.57M |
| Net tangible assets | - | 1164.03M | 953.92M | 756.99M | 593.28M |
| Short term investments | 17.23M | 15.44M | 13.76M | 13.45M | 17.75M |
| Net receivables | 485.04M | 408.43M | 328.73M | 305.06M | 308.99M |
| Long term debt | 145.50M | 149.27M | 152.88M | 112.54M | 325.22M |
| Inventory | - | 4.64M | -48741.99M | -13.45M | -17.75M |
| Accounts payable | 92.81M | 77.09M | 58.12M | 50.90M | 44.97M |
| Noncontrolling interest in consolidated entity | - | 1.47M | 0.95M | 0.15M | 1.95M |
| Accumulated other comprehensive income | 0.00M | - | - | -249.00M | -204.37M |
| Common stock total equity | - | 0.06M | 0.06M | 0.06M | 0.06M |
| Retained earnings total equity | - | 946.34M | 733.99M | 551.05M | 391.52M |
| Treasury stock | - | - | -83.04M | -71.21M | -45.30M |
| Non currrent assets other | 40.20M | -67547.06M | 47.05M | 33.26M | 40.26M |
| Non current assets total | 3130.61M | 2670.90M | 2210.91M | 1962.62M | 1950.83M |
| Capital lease obligations | 1721.85M | 1420.91M | 1108.70M | 998.51M | 1018.95M |
| Long term debt total | - | - | - | - | 325.22M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -180.16M | -7.62M | -4.78M | 2.67M | -17.52M |
| Change to liabilities | - | 77.65M | 7.12M | 99.00M | 69.48M |
| Total cashflows from investing activities | - | -186.18M | -173.91M | -58.67M | -247.01M |
| Net borrowings | - | -6.89M | 42.16M | -212.54M | 80.85M |
| Total cash from financing activities | -0.61M | -32.26M | -76.14M | -137.30M | 83.28M |
| Change to operating activities | - | 26.80M | 27.91M | 140.73M | 54.32M |
| Net income | 209.85M | 224.65M | 197.72M | 171.36M | 111.69M |
| Change in cash | 193.36M | 54.07M | 25.64M | 177.39M | 28.09M |
| Begin period cash flow | 316.27M | 262.20M | 236.56M | 59.17M | 31.08M |
| End period cash flow | 509.63M | 316.27M | 262.20M | 236.56M | 59.17M |
| Total cash from operating activities | 376.67M | 272.51M | 275.68M | 373.35M | 168.93M |
| Issuance of capital stock | 0.00M | 6.69M | 0.00M | - | - |
| Depreciation | 72.39M | 62.35M | 55.98M | 54.57M | 51.05M |
| Other cashflows from investing activities | - | -91.02M | 4.77M | -11.01M | -157.95M |
| Dividends paid | 12.89M | 12.17M | 11.55M | 10.83M | 10.19M |
| Change to inventory | 101.81M | - | 47.78M | 81.69M | 55.62M |
| Change to account receivables | -79.82M | -82.43M | -30.77M | 2.17M | -60.42M |
| Sale purchase of stock | -1.93M | -31.58M | -11.83M | -25.92M | -6.89M |
| Other cashflows from financing activities | -0.28M | 8.90M | -76.14M | -137.30M | 83.28M |
| Change to netincome | - | 17.02M | 23.67M | -3.55M | 46.62M |
| Capital expenditures | 106.18M | 87.55M | 69.55M | 50.33M | 71.54M |
| Change receivables | - | -82.43M | -30.77M | 2.17M | -60.42M |
| Cash flows other operating | - | -27.77M | -41.02M | 48.96M | -27.29M |
| Cash and cash equivalents changes | - | 54.07M | 25.64M | 177.39M | 28.09M |
| Change in working capital | 37.89M | -36.94M | 24.19M | 149.05M | 3.95M |
| Stock based compensation | 30.77M | 22.72M | 18.68M | 14.52M | 11.32M |
| Other non cash items | 53.25M | 6.23M | 3.99M | 11.65M | -12.57M |
| Free cash flow | 270.49M | 184.97M | 206.13M | 323.02M | 97.39M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ENSG The Ensign Group Inc |
1.54 0.83% |
187.73 | 31.38 | 22.17 | 1.82 | 4.55 | 2.18 | 23.03 |
| HCA HCA Healthcare, Inc. |
1.17 0.23% |
507.21 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-1.82 0.62% |
291.15 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.12 0.84% |
14.84 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
29222 Rancho Viejo Road, San Juan Capistrano, CA, United States, 92675
949 487 9500
35300
| Name | Title | Year Born |
|---|---|---|
| Mr. Barry R. Port | Pres, CEO & Director | 1974 |
| Ms. Suzanne D. Snapper | CFO, Exec. VP & Director | 1974 |
| Mr. Chad A. Keetch | Chief Investment Officer, Exec. VP & Sec. | 1978 |
| Mr. Spencer W. Burton | Pres & COO of Ensign Services, Inc. | 1979 |
| Ms. Beverly B. Wittekind | VP & Gen. Counsel | 1965 |
| Kevin Reese | Pres of Keystone Healthcare Inc | NA |
| Mr. Christopher R. Christensen | Co-Founder & Executive Chairman | 1969 |
| Mr. Barry R. Port | CEO & Director | 1974 |
| Ms. Suzanne D. Snapper | CFO, Executive VP & Director | 1974 |
| Mr. Chad A. Keetch | Chief Investment Officer, Executive VP & Secretary | 1978 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.